)
)
)
Ribonaut Therapeutics
Ribonaut is developing novel RNA-targeted therapies for CNS and oncology indications, with a lead program focused on Huntington disease that is approaching development candidate nomination. Supported by promising preclinical data showing strong target engagement, we are actively seeking connections to discuss our progress and explore collaboration opportunities across our platform.
Address
CambridgeMassachusetts
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)